AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
AdaptHealth Corp.NASDAQ: AHCO
Revenue · Q1 FY2026 · quarter ended Apr 2026
Revenue growth accelerates
Q1 FY2026 revenue of $819.8M rose 41.2% year over year, ahead of the +8.8% change in trailing-twelve-month revenue. Sequentially, it fell 3.1% from the prior quarter. Over 3 fiscal years it compounded at +3.0% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $2.91B (-10.4%) for the fiscal year ending Dec 2026, a slowdown from the -0.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $819.8M-3.1% QoQ
- Last fiscal yearDec 2025
- $3.24B-0.5% YoY
- LTMApr 2026
- $2.86B+8.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +41.2% | +43.4% | +2.2 pp |
| 1 year | -0.5% | -10.4% | -10.0 pp |
| 3-year CAGR | +3.0% | -1.3% | -4.3 pp |
| 5-year CAGR | +14.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 3.24B USD
- Year-over-year change
- -0.5%
- 4-year CAGR
- +7.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.24B | -0.5% |
| FY2024 | 2024-12-31 | 3.26B | +1.9% |
| FY2023 | 2023-12-31 | 3.2B | +7.7% |
| FY2022 | 2022-12-31 | 2.97B | +21.0% |
| FY2021 | 2021-12-31 | 2.45B | — |
Revenue vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 revenue of $2.86B is the 2nd highest of the 9 companies compared; the peer median is $319.03M.
- Its year-over-year change of +8.8% is the 5th highest of 9, against a peer median of +7.1%.
- Over three fiscal years its annual growth of +3.0% compares with a peer median of +12.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $5.65B | +9.9% | +10.2% | |
| LTM Apr 2026 | $2.86B | +8.8% | +3.0% | |
| LTM Mar 2026 | $1.03B | -6.8% | +8.2% | |
| LTM Jun 2026 | $898.74M | +4.3% | +30.8% | |
| LTM Mar 2026 | $351.5M | +3.4% | -2.6% | |
| LTM Mar 2026 | $286.57M | +23.1% | +24.9% | |
| LTM Mar 2026 | $142.4M | +3.5% | +9.3% | |
| LTM Mar 2026 | $110.24M | +57.9% | +724.3% | |
| LTM Mar 2026 | $71.75M | +16.8% | +15.4% | |
| Peer median (excluding AHCO) | $319.03M | +7.1% | +12.8% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B |
| Cost of Revenue | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B |
| Gross Profit | 445.61M | 417.43M | 681.77M | 681.09M | 568.56M |
| Gross Margin | 18.2% | 14.1% | 21.3% | 20.9% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 167.51M | 162.13M | 190.09M | 359.24M | 382.29M |
| Operating Expenses | 220.01M | 227.02M | 1.28B | 417.36M | 382.29M |
| Depreciation & Amortization | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M |
| EBITDA | 544.21M | 630.76M | (171.09M) | 628.02M | 503.64M |
| EBITDA Margin | 22.2% | 21.2% | -5.3% | 19.3% | 15.5% |
| Operating Income | 225.61M | 190.41M | (598.4M) | 263.73M | 186.27M |
| Operating Margin | 9.2% | 6.4% | -18.7% | 8.1% | 5.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.2M | 109.41M | 130.3M | 126.67M | 105.75M |
| Other Income / Expenses | (34.65M) | (92.51M) | (125.38M) | (127.71M) | (201.42M) |
| Income Before Tax | 190.96M | 97.9M | (723.78M) | 136.02M | (15.15M) |
| Pre-Tax Margin | 7.8% | 3.3% | -22.6% | 4.2% | -0.5% |
| Income Tax Expense | 32.81M | 24.77M | (49M) | 41.24M | 50.88M |
| Net Income | 156.18M | 69.32M | (678.9M) | 90.42M | (70.79M) |
| Net Margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| EPS (Basic) | 1.12 | 0.52 | (5.32) | 0.62 | (0.52) |
| EPS (Diluted) | 0.67 | 0.50 | (5.31) | 0.61 | (0.52) |
| Weighted Avg Shares | 126.31M | 134.18M | 134.16M | 133.76M | 135.15M |
| Weighted Avg Shares (Diluted) | 133.03M | 138.99M | 134.42M | 135.53M | 135.15M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.